GB9827348D0 - Natriuretic peptide - Google Patents

Natriuretic peptide

Info

Publication number
GB9827348D0
GB9827348D0 GBGB9827348.5A GB9827348A GB9827348D0 GB 9827348 D0 GB9827348 D0 GB 9827348D0 GB 9827348 A GB9827348 A GB 9827348A GB 9827348 D0 GB9827348 D0 GB 9827348D0
Authority
GB
United Kingdom
Prior art keywords
natriuretic peptide
natriuretic
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9827348.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Leicester
Original Assignee
University of Leicester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Leicester filed Critical University of Leicester
Priority to GBGB9827348.5A priority Critical patent/GB9827348D0/en
Publication of GB9827348D0 publication Critical patent/GB9827348D0/en
Application status is Ceased legal-status Critical

Links

GBGB9827348.5A 1998-12-12 1998-12-12 Natriuretic peptide Ceased GB9827348D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB9827348.5A GB9827348D0 (en) 1998-12-12 1998-12-12 Natriuretic peptide

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9827348.5A GB9827348D0 (en) 1998-12-12 1998-12-12 Natriuretic peptide
PCT/GB1999/004160 WO2000035951A1 (en) 1998-12-12 1999-12-09 Natriuretic peptide fragments
AU16703/00A AU1670300A (en) 1998-12-12 1999-12-09 Natriuretic peptide fragments

Publications (1)

Publication Number Publication Date
GB9827348D0 true GB9827348D0 (en) 1999-02-03

Family

ID=10844084

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9827348.5A Ceased GB9827348D0 (en) 1998-12-12 1998-12-12 Natriuretic peptide

Country Status (3)

Country Link
AU (1) AU1670300A (en)
GB (1) GB9827348D0 (en)
WO (1) WO2000035951A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1802602A (en) 2000-11-09 2002-05-21 Brigham & Womens Hospital Cardiovascular disease diagnostic and therapeutic targets
US7524635B2 (en) 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
AUPS169202A0 (en) * 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
AU2003234407B2 (en) 2002-05-09 2008-12-18 The Brigham And Women's Hospital, Inc. 1L1RL-1 as a cardiovascular disease marker and therapeutic target
FR2843396B1 (en) * 2002-08-07 2005-04-15 Bio Rad Pasteur specific antibodies for the diagnosis of heart failure
GB0224425D0 (en) * 2002-10-21 2002-11-27 Univ Leicester Method for prediction of cardiac disease
US20050287613A1 (en) * 2002-11-18 2005-12-29 George Jackowski Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP
US20040096919A1 (en) 2002-11-18 2004-05-20 Michelle Davey Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP
US6960472B2 (en) * 2002-11-18 2005-11-01 Ottawa Heart Institute Research Corporation Monoclonal antibodies against N-Terminus proBNP
WO2004046194A2 (en) * 2002-11-18 2004-06-03 Syn X Pharma, Inc. Polyclonal-monoclonal elisa assay for detecting n-terminus probnp
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
ES2548327T3 (en) 2003-05-12 2015-10-15 F. Hoffmann-La Roche Ag Method for detecting proBNP with a monoclonal antibody
GB2403533A (en) 2003-06-30 2005-01-05 Orion Corp Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof
DE10355731A1 (en) * 2003-11-28 2005-06-30 Roche Diagnostics Gmbh Analytical sandwich assay for the determination of NT-proBNP
AT500800B1 (en) 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh A method for determining proBNP
FR2863269B1 (en) * 2005-01-14 2006-05-26 Bio Rad Pasteur Peptides specific for the diagnosis of heart failure
ES2351623T3 (en) 2006-04-24 2011-02-08 Critical Care Diagnostics, Inc. Mortality prediction and detection of serious illness.
ES2566169T3 (en) 2006-05-01 2016-04-11 Critical Care Diagnostics, Inc. Diagnosis of cardiovascular disease
WO2007130627A2 (en) 2006-05-04 2007-11-15 The Brigham And Women's Hospital, Inc. Il-33 in the treatment and diagnosis of diseases and disorders
ES2430290T3 (en) * 2007-03-06 2013-11-19 F. Hoffmann-La Roche Ag Using PNC type peptides to predict the need for dialysis
AT504942B1 (en) 2007-03-07 2009-08-15 Biomedica Medizinprodukte Gmbh A method for determining proBNP
US9482677B2 (en) 2008-02-27 2016-11-01 Scios Inc. Method, composition and device for sampling natriuretic peptides in a biological fluid
PT2827152T (en) * 2008-04-18 2016-09-13 Critical Care Diagnostics Inc Predicting risk of major adverse cardiac events
EP2601531A1 (en) 2010-08-04 2013-06-12 IDEXX Laboratories, Inc. Detection of degradation products of canine nt-probnp
JP6215713B2 (en) 2011-03-17 2017-10-18 クリティカル ケア ダイアグノスティクス インコーポレイテッド Method for predicting the risk of adverse clinical outcomes
US8481333B2 (en) 2011-05-31 2013-07-09 Idexx Laboratories, Inc. Detection of degradation products of feline NT-proBNP
CN102854321B (en) * 2012-07-26 2015-09-02 博奥赛斯(天津)生物科技有限公司 N-terminal chemical precursor b-type natriuretic peptide Immunoassay luminescent detection kit and its preparation method
CN107478848A (en) * 2017-08-23 2017-12-15 广州瑞博奥生物科技有限公司 Kit for quantitatively detecting NT-proBNP (N-terminal prohormone Brain Natriuretic Peptide) and preparation method of kit

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
EP2292662B1 (en) * 1996-03-04 2014-04-23 Scios Inc. Assay and reagents for quantifying hBNP

Also Published As

Publication number Publication date
WO2000035951A1 (en) 2000-06-22
AU1670300A (en) 2000-07-03

Similar Documents

Publication Publication Date Title
DE59912562D1 (en) Indolyl-3-glyoxylsäure-derivate mit antitumorwirkung
DE69826273D1 (en) Knochentransplantat-composite und -spacern
DE69800640D1 (en) Pegylationsverfahren
DE69826254D1 (en) Modulare humerusprothese
DE69807872D1 (en) Thermoplastisches polyetherurethan
DE69821950D1 (en) N-aroylphenylalaninderivate
DE69817191D1 (en) Roboter-mäher
DE69837675D1 (en) Pyrazolderivate
DE69831868D1 (en) Antithrombosemittel
DE69804946D1 (en) Opthalmische formmasse
DE69808438D1 (en) Hüftprothese
DE69810130D1 (en) Rotationspumpe mit tauchrotor
DE69809754D1 (en) Substituierte 6-phenylphenanthridine
DE69827940D1 (en) Thiarylsulfonamid-hydroxamsäurederivate
DE69837702D1 (en) Lastsensor
DE69840963D1 (en) Thermale therapievorrichtung
DE59804066D1 (en) Triazolinthion-phosphorsäure-derivate
CZ9903517A3 (en) Substituted 3-cynoquinolines
DE69838100D1 (en) Gefässprothese
DE69827236D1 (en) Matrix-metalloproteinase-hemmer
GB9825535D0 (en) Pyrometer-multimeter
HK1038025A1 (en) Novel anti-diabetic peptides
DE69820902D1 (en) Snowboardkörper
EP1022970A4 (en) Playyard
EP1012260A4 (en) Interleukin-20

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)